KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

1 800 Flowers Com (FLWS) Asset Writedowns and Impairment (2016 - 2025)

1 800 Flowers Com (FLWS) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $58000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $58000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.8 million through Dec 2025, up 117769.67% year-over-year, with the annual reading at $143.8 million for FY2025, 626.38% up from the prior year.
  • Asset Writedowns and Impairment hit $58000.0 in Q4 2025 for 1 800 Flowers Com, up from $4000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $138.2 million in Q1 2025 to a low of -$1.3 million in Q4 2021.
  • Historically, Asset Writedowns and Impairment has averaged $17.6 million across 5 years, with a median of $265000.0 in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 306.92% in 2021 and later soared 14476.32% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$1.3 million in 2021, then soared by 120.62% to $265000.0 in 2022, then skyrocketed by 7371.7% to $19.8 million in 2023, then crashed by 99.58% to $84000.0 in 2024, then tumbled by 30.95% to $58000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for FLWS at $58000.0 in Q4 2025, $4000.0 in Q3 2025, and $5.5 million in Q2 2025.